SPY313.56+3.04 0.98%
DIA259.95+2.64 1.02%
IXIC10,251.98+97.35 0.96%

Baird Maintains Outperform on DexCom, Raises Price Target to $240

Baird maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $195 to $240.

Benzinga · -

Baird maintains DexCom (NASDAQ:DXCM) with a Outperform and raises the price target from $195 to $240.